raloxifene hydrochloride has been researched along with Femoral Neck Fractures in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, Y | 1 |
| Flik, KR; Gardner, MJ; Lane, JM; Mooar, P | 1 |
| Hosoi, T | 1 |
| Nakamura, T | 2 |
| Mori, S | 1 |
| Ohta, H | 1 |
| Cummings, SR; Diez-Perez, A; Eastell, R; Goemaere, S; Harris, ST; Kulkarni, PM; Qu, Y; Siddhanti, SR; Siris, ES; Song, J; Stock, JL; Wong, M; Zanchetta, JR | 1 |
| Soen, S | 1 |
6 review(s) available for raloxifene hydrochloride and Femoral Neck Fractures
| Article | Year |
|---|---|
[Prevention of fractures with therapeutic agents for osteoporosis].
Topics: Aged; Bone Density; Diphosphonates; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Femoral Neck Fractures; Humans; Meta-Analysis as Topic; Osteoporosis; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Spinal Fractures | 2004 |
[Bone quality in treatment with raroxifene ].
Topics: Bone Density; Etidronic Acid; Evidence-Based Medicine; Femoral Neck Fractures; Humans; Meta-Analysis as Topic; Osteoporosis; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Regression Analysis; Reproducibility of Results; Risedronic Acid; Spinal Fractures; Testosterone | 2004 |
[Contribution of bone quality to fracture risk].
Topics: Bone and Bones; Bone Density; Bone Matrix; Bone Remodeling; Calcification, Physiologic; Controlled Clinical Trials as Topic; Female; Femoral Neck Fractures; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk; Selective Estrogen Receptor Modulators; Spinal Fractures | 2004 |
[Defining the role of raloxifene as a therapeutic agent for postmenopausal osteoporosis: focus on its pharmacological properties].
Topics: Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Female; Femoral Neck Fractures; Humans; Osteocalcin; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Spinal Fractures | 2004 |
[First choice drug for treatment of osteoporosis and the strategic points for choice of drugs].
Topics: Bone Density; Bone Density Conservation Agents; Calcium; Cholecalciferol; Diphosphonates; Evidence-Based Medicine; Femoral Neck Fractures; Humans; Meta-Analysis as Topic; Osteoporosis; Practice Guidelines as Topic; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Spinal Fractures | 2007 |
[Treatment of osteoporosis: overview].
Topics: Bone Density; Clinical Trials as Topic; Diphosphonates; Estrogen Replacement Therapy; Evidence-Based Medicine; Femoral Neck Fractures; Fractures, Stress; Humans; Osteoporosis; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Spinal Fractures | 2002 |
1 trial(s) available for raloxifene hydrochloride and Femoral Neck Fractures
| Article | Year |
|---|---|
Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
Topics: Aged; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Breast Neoplasms; Double-Blind Method; Female; Femoral Neck Fractures; Femur Neck; Fracture Healing; Fractures, Bone; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Placebos; Poisson Distribution; Postmenopause; Proportional Hazards Models; Raloxifene Hydrochloride; Risk; Time Factors; Treatment Outcome | 2005 |
2 other study(ies) available for raloxifene hydrochloride and Femoral Neck Fractures
| Article | Year |
|---|---|
[Economics of medicament therapies for osteoporosis].
Topics: Bone Density Conservation Agents; Drug Costs; Femoral Neck Fractures; Humans; Hydroxycholecalciferols; Japan; Low Back Pain; Osteoporosis; Protective Devices; Raloxifene Hydrochloride | 2009 |
Improvement in the undertreatment of osteoporosis following hip fracture.
Topics: Aged; Aged, 80 and over; Calcitonin; Calcium; Female; Femoral Neck Fractures; Hip Fractures; Humans; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Practice Patterns, Physicians'; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; United States | 2002 |